1
|
Ding Y, Zhang Z, Ding C, Xu S, Xu Z. The Use of Cyclodextrin Inclusion Complexes to Increase the Solubility and Pharmacokinetic Profile of Albendazole. Molecules 2023; 28:7295. [PMID: 37959715 PMCID: PMC10648351 DOI: 10.3390/molecules28217295] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2023] [Revised: 10/21/2023] [Accepted: 10/25/2023] [Indexed: 11/15/2023] Open
Abstract
Albendazole is the preferred deworming drug and has strong insecticidal effects on human and animal helminth parasites, showing remarkable activity against hepatocellular carcinoma and colorectal cancer cells. However, it is classified as being in class II in the Biopharmaceutics Classification System due to its poor water solubility (0.2 mg/L) and high permeability, which make the clinical application of albendazole impractical. Through complexation with methyl-β-cyclodextrin, as the best result so far, albendazole's water solubility was increased by 150,000 times, and albendazole could be 90% released during the first 10 min. In an in vivo pharmacokinetic study, the Cmax and Tmax of the active metabolized sulfoxide were changed from 2.81 µg/mL at 3 h to 10.2 µg/mL at 6 h and the AUC0-48 was increased from 50.72 h⁎μg/mL to 119.95 h⁎μg/mL, indicating that the inclusion complex obtained can be used as a new oral therapeutic anti-anthelmintic and anti-tumor agent formulation.
Collapse
Affiliation(s)
- Yili Ding
- College of Science and Technology, Wenzhou-Kean University, Wenzhou 325000, China
- Wenzhou Municipal Key Laboratory for Applied Biomedical and Biopharmaceutical Informatics, Wenzhou-Kean University, Wenzhou 325060, China
- Zhejiang Bioinformatics International Science and Technology Cooperation Center, Wenzhou-Kean University, Wenzhou 325060, China
- Dorothy and George Hennings College of Science, Mathematics and Technology, Kean University, 1000 Morris Ave, Union, NJ 07083, USA
| | - Zhiyuan Zhang
- Life Science Department, Foshan University, Foshan 528000, China
| | - Charles Ding
- Keck School of Medicine of USC, Los Angeles, CA 90089, USA
| | - Shufeng Xu
- Life Science Department, Foshan University, Foshan 528000, China
| | - Zhe Xu
- College of Science and Technology, Wenzhou-Kean University, Wenzhou 325000, China
| |
Collapse
|
2
|
Rahman M, Singh JG, Afzal O, Altamimi AS, Alrobaian M, Haneef J, Barkat MA, Almalki WH, Handa M, Shukla R, Nasar Mir Najib Ullah S, Kumar V, Beg S. Preparation, Characterization, and Evaluation of Curcumin-Graphene Oxide Complex-Loaded Liposomes against Staphylococcus aureus in Topical Disease. ACS OMEGA 2022; 7:43499-43509. [PMID: 36506117 PMCID: PMC9730485 DOI: 10.1021/acsomega.2c03940] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/23/2022] [Accepted: 10/17/2022] [Indexed: 06/17/2023]
Abstract
This study describes the development and characterization of curcumin with graphene oxide complex (CUR + GO) loaded into liposomes for treating skin disease. The developed complex was characterized by X-ray diffraction and showed a broad halo pattern, confirming the amorphous nature of the resulting complex. Furthermore, scanning electron microscopy revealed the irregular porous morphology of the complex-highlighting loss of the crystallinity and the emergence of the amorphous phase. Additionally, the liposomes showed long-term stability at 2-8 °C and 25 ± 2 °C/60 ± 5%RH with nonsignificant variations in the particle size, polydispersity index, and zeta potential. Overall, optical and high-resolution transmission electron microscopy images of liposomes showed a consistent shape, and no aggregation with uniform particle size distribution was observed. Furthermore, the cumulative drug release in the first 6 h was 71.24 and 64.24% for CUR-loaded liposomes and CUR-GO-loaded liposomes, respectively. The lower value of drug release might be attributed to the complex development. The drug release model found the first order with non-Fickian diffusion process, which is often observed at higher n > 0.5. The antibacterial activity of the CUR with GO-loaded liposome (D2) offered higher anti-microbial activity over other formulations against the mentioned bacterial microorganism that causes skin diseases.
Collapse
Affiliation(s)
- Mahfoozur Rahman
- Department
of Pharmaceutical Sciences, Shalom Institute of Health & Allied
Sciences, Sam Higginbottom University of
Agriculture, Technology & Sciences, Allahabad211007, India
| | - Joina Gunjan Singh
- Department
of Pharmaceutical Sciences, Shalom Institute of Health & Allied
Sciences, Sam Higginbottom University of
Agriculture, Technology & Sciences, Allahabad211007, India
| | - Obaid Afzal
- Department
of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj11942, Saudi Arabia
| | | | - Majed Alrobaian
- Department
of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif21944, Saudi Arabia
| | - Jamshed Haneef
- Department
of Pharmaceutical Chemistry, School of Pharmaceutical
Education and Research, Jamia Hamdard, New Delhi110062, India
| | - Md. Abul Barkat
- Department
of Pharmaceutics, College of Pharmacy, University
of Hafr Al Batin, Hafr Al
Batin39524, Saudi Arabia
| | - Waleed H Almalki
- Department
of Pharmacology and Toxicology, College of Pharmacy, Umm Al-Qura University, Makkah24382, Saudi Arabia
| | - Mayank Handa
- Department
of Pharmaceutics, National Institute of
Pharmaceutical Education and Research-Raebareli, Lucknow, UP226002, India
| | - Rahul Shukla
- Department
of Pharmaceutics, National Institute of
Pharmaceutical Education and Research-Raebareli, Lucknow, UP226002, India
| | | | - Vikas Kumar
- Department
of Pharmaceutical Sciences, Shalom Institute of Health & Allied
Sciences, Sam Higginbottom University of
Agriculture, Technology & Sciences, Allahabad211007, India
| | - Sarwar Beg
- Department
of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi110062, India
| |
Collapse
|
3
|
Hernández-Castillo DJ, de la Cruz Hernández EN, Frías Márquez DM, Tilley RD, Gloag L, Owen PQ, López González R, Alvarez Lemus MA. Albendazole Release from Silica-Chitosan Nanospheres. In Vitro Study on Cervix Cancer Cell Lines. Polymers (Basel) 2021; 13:1945. [PMID: 34208138 PMCID: PMC8230914 DOI: 10.3390/polym13121945] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2021] [Revised: 06/02/2021] [Accepted: 06/09/2021] [Indexed: 02/07/2023] Open
Abstract
In this work, a pH-responsive drug-carrier based on chitosan-silica nanospheres was developed as a carrier for Albendazole (ABZ), a poorly water-soluble anthelmintic drug. Spherical silica nanoparticles were obtained by Stöber method and further etched to obtain mesoporous particles with sizes ranging from 350 to 400 nm. The specific BET area of nanoparticles increased from 15 m2/g to 150 m2/g for etched silica, which also exhibited a uniform pore size distribution. X-ray powder diffraction showed the presence of amorphous phase of silica and a low-intensity peak attributed to ABZ for the drug-loaded nanoparticles. A uniform layer of chitosan was obtained ranging from 10 to 15 nm in thickness due to the small concentration of chitosan used (0.45 mg of chitosan/mg of SiO2). The in vitro evaluation of hybrid nanoparticles was performed using four cervical cancer cell lines CaSki, HeLa, SiHa and C33A, showing a significant reduction in cell proliferation (>85%) after 72 h. Therefore, we confirmed the encapsulation and bioavailability of the drug, which was released in a controlled way, and the presence of chitosan delayed the release, which could be of interest for the development of prolonged release drug delivery systems.
Collapse
Affiliation(s)
- Daniela J. Hernández-Castillo
- Laboratorio de Nanotecnología-CICTAT, División Académica de Ingeniería y Arquitectura, Universidad Juárez Autónoma de Tabasco, Carr. Cunduacán-Jalpa de Méndez, Km 1 Cunduacán, Tabasco 86690, Mexico; (D.J.H.-C.); (D.M.F.M.); (R.L.G.)
| | | | - Dora M. Frías Márquez
- Laboratorio de Nanotecnología-CICTAT, División Académica de Ingeniería y Arquitectura, Universidad Juárez Autónoma de Tabasco, Carr. Cunduacán-Jalpa de Méndez, Km 1 Cunduacán, Tabasco 86690, Mexico; (D.J.H.-C.); (D.M.F.M.); (R.L.G.)
| | - Richard D. Tilley
- School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia; (R.D.T.); (L.G.)
| | - Lucy Gloag
- School of Chemistry, University of New South Wales, Sydney, NSW 2052, Australia; (R.D.T.); (L.G.)
| | - Patricia Quintana Owen
- Departamento de Física Aplicada, Centro de Investigación y de Estudios Avanzados del IPN Unidad Mérida, AP 73 Cordemx, Mérida 97310, Mexico;
| | - Rosendo López González
- Laboratorio de Nanotecnología-CICTAT, División Académica de Ingeniería y Arquitectura, Universidad Juárez Autónoma de Tabasco, Carr. Cunduacán-Jalpa de Méndez, Km 1 Cunduacán, Tabasco 86690, Mexico; (D.J.H.-C.); (D.M.F.M.); (R.L.G.)
| | - Mayra A. Alvarez Lemus
- Laboratorio de Nanotecnología-CICTAT, División Académica de Ingeniería y Arquitectura, Universidad Juárez Autónoma de Tabasco, Carr. Cunduacán-Jalpa de Méndez, Km 1 Cunduacán, Tabasco 86690, Mexico; (D.J.H.-C.); (D.M.F.M.); (R.L.G.)
| |
Collapse
|
4
|
Hemmingsen LM, Julin K, Ahsan L, Basnet P, Johannessen M, Škalko-Basnet N. Chitosomes-In-Chitosan Hydrogel for Acute Skin Injuries: Prevention and Infection Control. Mar Drugs 2021; 19:269. [PMID: 34065943 PMCID: PMC8150996 DOI: 10.3390/md19050269] [Citation(s) in RCA: 26] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2021] [Revised: 05/04/2021] [Accepted: 05/10/2021] [Indexed: 01/12/2023] Open
Abstract
Burns and other skin injuries are growing concerns as well as challenges in an era of antimicrobial resistance. Novel treatment options to improve the prevention and eradication of infectious skin biofilm-producing pathogens, while enhancing wound healing, are urgently needed for the timely treatment of infection-prone injuries. Treatment of acute skin injuries requires tailoring of formulation to assure both proper skin retention and the appropriate release of incorporated antimicrobials. The challenge remains to formulate antimicrobials with low water solubility, which often requires carriers as the primary vehicle, followed by a secondary skin-friendly vehicle. We focused on widely used chlorhexidine formulated in the chitosan-infused nanocarriers, chitosomes, incorporated into chitosan hydrogel for improved treatment of skin injuries. To prove our hypothesis, lipid nanocarriers and chitosan-comprising nanocarriers (≈250 nm) with membrane-active antimicrobial chlorhexidine were optimized and incorporated into chitosan hydrogel. The biological and antibacterial effects of both vesicles and a vesicles-in-hydrogel system were evaluated. The chitosomes-in-chitosan hydrogel formulation demonstrated promising physical properties and were proven safe. Additionally, the chitosan-based systems, both chitosomes and chitosan hydrogel, showed an improved antimicrobial effect against S. aureus and S. epidermidis compared to the formulations without chitosan. The novel formulation could serve as a foundation for infection prevention and bacterial eradication in acute wounds.
Collapse
Affiliation(s)
- Lisa Myrseth Hemmingsen
- Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway; (L.M.H.); (L.A.)
| | - Kjersti Julin
- Research Group for Host-Microbe Interaction, Department of Medical Biology, University of Tromsø The Arctic University of Norway, Sykehusvegen 44, 9037 Tromsø, Norway; (K.J.); (M.J.)
| | - Luqman Ahsan
- Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway; (L.M.H.); (L.A.)
| | - Purusotam Basnet
- IVF Clinic, Department of Obstetrics and Gynecology, University Hospital of North Norway, Sykehusvegen 38, 9019 Tromsø, Norway;
- Women’s Health and Perinatology Research Group, Department of Clinical Medicine, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway
| | - Mona Johannessen
- Research Group for Host-Microbe Interaction, Department of Medical Biology, University of Tromsø The Arctic University of Norway, Sykehusvegen 44, 9037 Tromsø, Norway; (K.J.); (M.J.)
| | - Nataša Škalko-Basnet
- Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø The Arctic University of Norway, Universitetsvegen 57, 9037 Tromsø, Norway; (L.M.H.); (L.A.)
| |
Collapse
|
5
|
Sekharan TR, Katari O, Ruhina Rahman SN, Pawde DM, Goswami A, Chandira RM, Shunmugaperumal T. Neoteric solvents for the pharmaceutical industry: an update. Drug Discov Today 2021; 26:1702-1711. [PMID: 33737071 DOI: 10.1016/j.drudis.2021.03.005] [Citation(s) in RCA: 7] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/10/2020] [Revised: 02/16/2021] [Accepted: 03/09/2021] [Indexed: 12/23/2022]
Affiliation(s)
- Thenrajan Raja Sekharan
- Department of Pharmaceutics, Vinayaka Mission's College of Pharmacy, Vinayaka Mission's Research Foundation (Deemed to be University), Salem, 636308, Tamil Nadu, India; Department of Pharmaceutics, Sankaralingam Bhuvaneswari College of Pharmacy, Anaikuttam, 626130, Sivakasi, Tamil Nadu, India
| | - Oly Katari
- National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur (Halugurisuk), Changsari, Kamrup, Assam, 781101, India
| | - Syed Nazrin Ruhina Rahman
- National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur (Halugurisuk), Changsari, Kamrup, Assam, 781101, India
| | - Datta Maroti Pawde
- National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur (Halugurisuk), Changsari, Kamrup, Assam, 781101, India
| | - Abhinab Goswami
- National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur (Halugurisuk), Changsari, Kamrup, Assam, 781101, India
| | - Rajappa Margret Chandira
- Department of Pharmaceutics, Vinayaka Mission's College of Pharmacy, Vinayaka Mission's Research Foundation (Deemed to be University), Salem, 636308, Tamil Nadu, India
| | - Tamilvanan Shunmugaperumal
- National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, Sila Katamur (Halugurisuk), Changsari, Kamrup, Assam, 781101, India.
| |
Collapse
|
6
|
|
7
|
Maqbool F, Falconer JR, Moyle PM. Supercritical fluid assembly of albendazole liposomes targeting gastrin-releasing peptide receptor overexpressing tumors. Nanomedicine (Lond) 2020; 15:1315-1330. [PMID: 32484025 DOI: 10.2217/nnm-2020-0048] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022] Open
Abstract
Aim: To develop albendazole (ABZ)-loaded bombesin(6-14) (BBN(6-14)) functionalized liposomes for targeting GRPR to enhance delivery to cancer cells. Materials & methods: ABZ-loaded liposomes were formulated using supercritical CO2 technology; functionalized with a GRPR-targeted lipid-anchored BBN(6-14) peptide; and evaluated for effects on cell viability, particle size and targeted cell uptake. Results: BBN(6-14)-coated ABZ liposomes decreased cell viability compared with nonfunctionalized ABZ liposomes. The level of GRPR expression positively correlated with intracellular uptake and decreased cell viability. The reduced cell viability, higher cell uptake and GRPR expression were observed in the order PC-3 > Caco-2 > HepG2 cells. Conclusion: BBN(6-14)-functionalized ABZ liposomes showed enhanced reduction in cell viability compared with nonfunctionalized ABZ liposomes.
Collapse
Affiliation(s)
- Faheem Maqbool
- School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia
| | - James R Falconer
- School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia
| | - Peter M Moyle
- School of Pharmacy, The University of Queensland, Woolloongabba, QLD, 4102, Australia
| |
Collapse
|
8
|
Chakravarty P, Famili A, Nagapudi K, Al-Sayah MA. Using Supercritical Fluid Technology as a Green Alternative During the Preparation of Drug Delivery Systems. Pharmaceutics 2019; 11:E629. [PMID: 31775292 PMCID: PMC6956038 DOI: 10.3390/pharmaceutics11120629] [Citation(s) in RCA: 56] [Impact Index Per Article: 11.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/03/2019] [Revised: 11/13/2019] [Accepted: 11/18/2019] [Indexed: 12/17/2022] Open
Abstract
Micro- and nano-carrier formulations have been developed as drug delivery systems for active pharmaceutical ingredients (APIs) that suffer from poor physico-chemical, pharmacokinetic, and pharmacodynamic properties. Encapsulating the APIs in such systems can help improve their stability by protecting them from harsh conditions such as light, oxygen, temperature, pH, enzymes, and others. Consequently, the API's dissolution rate and bioavailability are tremendously improved. Conventional techniques used in the production of these drug carrier formulations have several drawbacks, including thermal and chemical stability of the APIs, excessive use of organic solvents, high residual solvent levels, difficult particle size control and distributions, drug loading-related challenges, and time and energy consumption. This review illustrates how supercritical fluid (SCF) technologies can be superior in controlling the morphology of API particles and in the production of drug carriers due to SCF's non-toxic, inert, economical, and environmentally friendly properties. The SCF's advantages, benefits, and various preparation methods are discussed. Drug carrier formulations discussed in this review include microparticles, nanoparticles, polymeric membranes, aerogels, microporous foams, solid lipid nanoparticles, and liposomes.
Collapse
Affiliation(s)
- Paroma Chakravarty
- Small Molecule Pharmaceutics, Genentech, Inc. So. San Francisco, CA 94080, USA; (P.C.); (K.N.)
| | - Amin Famili
- Small Molecule Analytical Chemistry, Genentech, Inc. So. San Francisco, CA 94080, USA;
| | - Karthik Nagapudi
- Small Molecule Pharmaceutics, Genentech, Inc. So. San Francisco, CA 94080, USA; (P.C.); (K.N.)
| | - Mohammad A. Al-Sayah
- Small Molecule Analytical Chemistry, Genentech, Inc. So. San Francisco, CA 94080, USA;
| |
Collapse
|